Johnson & Johnson Foreign Currency Derivative Instruments Not Designated as Hedging Instruments, Asset at Fair Value
Johnson & Johnson (JNJ) had Foreign Currency Derivative Instruments Not Designated as Hedging Instruments, Asset at Fair Value of $75.00 million as of 2012-12-30, per its 10-K filed 2013-02-22.
Discontinued › Notes › Derivative Instruments and Hedging Activities
us-gaap:ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue · last filed 2013-02-22
- 2012-12-30: Foreign Currency Derivative Instruments Not Designated as Hedging Instruments, Asset at Fair Value $75.00M.
- 2012-09-30: Foreign Currency Derivative Instruments Not Designated as Hedging Instruments, Asset at Fair Value $18.00M.
- 2012-07-01: Foreign Currency Derivative Instruments Not Designated as Hedging Instruments, Asset at Fair Value $22.00M.
- 2012-04-01: Foreign Currency Derivative Instruments Not Designated as Hedging Instruments, Asset at Fair Value $23.00M.
| Period end | Foreign Currency Derivative Instruments Not Designated as Hedging Instruments, Asset at Fair Value |
|---|---|
| 2012-12-30 | $75.00M 10-K · filed 2013-02-22 |
| 2012-09-30 | $18.00M 10-Q · filed 2012-11-09 |
| 2012-07-01 | $22.00M 10-Q · filed 2012-08-02 |
| 2012-04-01 | $23.00M 10-Q · filed 2012-05-07 |
| 2012-01-01 | $46.00M 10-K · filed 2012-02-23 |
| 2011-10-02 | $285.00M 10-Q · filed 2011-11-08 |
| 2011-07-03 | $597.00M 10-Q · filed 2011-08-09 |
| 2011-01-02 | $19.00M 10-K · filed 2012-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| Merck & Co., Inc. (MRK) | United States | $365.215B | 99.96 |
| ELI LILLY & Co (LLY) | United States | $1,113.804B | 42.28 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |